Inclusion Criteria:

Patients will be considered for enrolment if they meet the criteria of:

• A confirmed diagnosis of ADHD based on the DSM-5 criteria for ADHD (Western medical diagnosis) and in accordance with the ADHD Chinese Medicine Clinical Trial Design and Evaluation Technical Guidelines.
• Aged between 6 and 12 years.
• No use of any other pharmacological treatments (both Western and traditional Chinese medicine) within the two weeks prior to the start of the study.
• An IQ score of greater than 80, as determined by the Raven's Progressive Matrices test.
• The participant has not participated in any other clinical trials.

Exclusion Criteria:

Patients will be excluded from the study if they meet any of the following criteria:

• Do not meet the inclusion criteria
• Have comorbid psychiatric disorders, severe medical or psychiatric conditions that may interfere with the study (e.g., epilepsy, severe anxiety), pervasive developmental disorders, intellectual disability, or a history of suicidal or self-harming behavior
• Have participated in any other drug clinical trials within the past 3 months.
• Have severe comorbid conditions such as cardiovascular, hepatic, renal, or hematologic diseases.
• Have any other conditions that the researchers believe may interfere with the assessment of treatment efficacy or safety.